Severe insulin resistance sits at the far end of metabolic dysfunction, where the body requires unusually high insulin levels to maintain glucose balance. Although common insulin resistance appears in obesity, prediabetes, type 2 diabetes, and PCOS, severe patterns often point toward deeper endocrine, immune, genetic, or fat-distribution drivers.
As an endocrinologist, diabetes specialist, lipidologist, clinical hypertension specialist, and obesity specialist, I view these syndromes through a broader context. Glucose values matter, yet insulin levels, triglycerides, liver fat, androgen excess, body composition, and skin findings often tell the fuller story.
What Severe Insulin Resistance Means
Insulin helps move glucose into muscle, liver, and fat cells. When tissues resist insulin’s signal, the pancreas compensates by producing more insulin. Over time, that compensation can become extreme.
Severe insulin resistance may appear with very high fasting insulin levels, unusually high insulin requirements, difficult-to-control diabetes, or striking physical findings. These may include dark velvety skin changes, skin tags, central fat accumulation, loss of fat in unusual areas, ovarian androgen excess, fatty liver, or very high triglycerides.
This distinction matters because severe insulin resistance does not always come from lifestyle alone. Sometimes the pattern reflects rare biology that requires a more thoughtful diagnostic lens.
Common Clues That Suggest a More Severe Pattern
Many patients with severe insulin resistance first notice visible or hormonal clues before glucose becomes severely abnormal. The skin often provides early evidence, especially through acanthosis nigricans around the neck, underarms, or groin.
Women may also develop irregular periods, acne, scalp hair thinning, or excess facial hair. In some cases, these symptoms overlap with PCOS, but the severity of insulin resistance may point toward HAIR-AN syndrome or another diagnosis.
| Clinical Clue | Why It Matters |
| Acanthosis nigricans | Suggests high insulin exposure over time |
| Very high triglycerides | Points toward metabolic stress or lipodystrophy |
| High insulin requirements | Raises concern for severe resistance |
| Fat loss in limbs or face | May suggest lipodystrophy |
| Severe androgen excess | May suggest HAIR-AN, PCOS overlap, or ovarian disease |
Key Severe Insulin Resistance Syndromes
These patterns begin to separate into distinct syndromes, each with its own physiology and implications.
- Type A Insulin Resistance: Type A insulin resistance often affects younger women and frequently stems from genetic or inherited insulin receptor pathway abnormalities. Patients may have normal or lean body weight, but still develop marked insulin resistance, acanthosis nigricans, irregular periods, and androgen excess. This pattern can mimic PCOS, but the degree of insulin resistance may appear disproportionate to body size. That mismatch becomes an important diagnostic clue.
- Type B Insulin Resistance: Type B insulin resistance results from antibodies that interfere with insulin receptors. It often occurs alongside autoimmune disease, especially lupus or other connective tissue disorders. This condition can cause dramatic glucose instability. Some patients develop severe hyperglycemia, while others experience unexpected hypoglycemia depending on antibody behavior. Because the immune system drives the problem, management often requires coordinated endocrine and rheumatologic care.
- HAIR-AN Syndrome: HAIR-AN stands for hyperandrogenism, insulin resistance, and acanthosis nigricans. It overlaps with PCOS, but often presents with more striking insulin resistance and more visible skin findings. Women may experience irregular cycles, hirsutism, acne, metabolic syndrome, and weight difficulty. A thoughtful approach looks beyond testosterone alone and considers insulin as a driver of ovarian androgen production.
- Lipodystrophy Syndromes: Lipodystrophy involves abnormal loss or redistribution of body fat. Because healthy fat tissue helps store energy safely, its absence can push fat into the liver, muscle, and bloodstream. Patients may develop severe insulin resistance, fatty liver, high triglycerides, pancreatitis risk, and diabetes despite not appearing traditionally overweight. This is a powerful example of why body composition matters more than scale weight alone.
| Syndrome | Typical Clues | Broader Pattern |
| Type A insulin resistance | Young woman, lean or normal weight, acanthosis | Insulin receptor pathway problem |
| Type B insulin resistance | Autoimmune disease, unstable glucose | Insulin receptor antibodies |
| HAIR-AN | Acanthosis, androgen excess, irregular cycles | PCOS-like but often more severe |
| Lipodystrophy | Fat loss, high triglycerides, fatty liver | Unsafe fat storage biology |
How Evaluation Should Be Structured
A meaningful evaluation starts by confirming the pattern rather than reacting to one abnormal value. Fasting glucose and A1C show part of the story, but they may underestimate insulin resistance early.
Additional testing may include fasting insulin (though in extreme cases or late stages, beta-cell burnout may cause initially high insulin levels to drop), C-peptide, lipid markers, liver enzymes, testosterone, DHEA-S, SHBG, ovarian evaluation, autoimmune markers, and body composition assessment. In selected cases, genetic testing or specialized evaluation becomes appropriate.
The goal is not to label every patient with a rare syndrome. Instead, the goal is to recognize when the pattern looks more intense, atypical, or disproportionate.
Patient Case Variations
- Case 1 — Type A Pattern in a Lean Woman: A 22-year-old woman has irregular cycles, acne, and darkening around her neck. Her BMI is normal, yet fasting insulin is markedly elevated. PCOS seems possible, but the severity appears disproportionate. Further evaluation supports a severe insulin resistance pattern requiring targeted metabolic and hormonal care.
- Case 2 — HAIR-AN With PCOS Overlap: A 31-year-old woman presents with hirsutism, weight gain, acanthosis nigricans, and irregular periods. Her triglycerides are elevated and SHBG is low. Insulin resistance appears central to her androgen excess. Nutrition, strength training, weight reduction, and insulin-sensitizing therapy improve her cycles and metabolic markers.
- Case 3 — Lipodystrophy Misread as “Not Overweight”: A 42-year-old man has severe hypertriglyceridemia, fatty liver, and diabetes despite limited abdominal fat. His arms and legs appear unusually muscular because of fat loss. The pattern suggests abnormal fat storage rather than simple lifestyle-driven diabetes. Treatment focuses on triglyceride control, liver risk, and insulin sensitivity.
- Case 4 — Autoimmune Type B Insulin Resistance: A 48-year-old woman with autoimmune disease develops sudden severe hyperglycemia despite escalating insulin doses. She also has weight loss and fluctuating glucose patterns. Antibody testing raises concern for Type B insulin resistance. Coordinated immune and endocrine management becomes essential.
- Case 5 — Severe Obesity-Related Insulin Resistance: A 55-year-old man requires very high insulin doses and has fatty liver, hypertension, sleep apnea, and high triglycerides. His pattern reflects severe common insulin resistance rather than a rare receptor disorder. A comprehensive plan addresses weight, sleep, liver fat, lipids, blood pressure, and medication strategy together.
Treatment Requires More Than Glucose Control
Treatment depends on the cause. Common severe insulin resistance often improves with weight reduction, resistance training, sleep optimization, nutrition changes, and medications such as metformin, GLP-1-based therapy, or other diabetes treatments.
However, rare syndromes may require additional strategies. Type B insulin resistance may need immune-directed therapy. Lipodystrophy may require aggressive triglyceride management and specialized metabolic care, such as leptin replacement therapy. HAIR-AN often improves when treatment addresses both insulin resistance and androgen excess together.
Matching treatment to the underlying biology, rather than focusing on glucose alone, creates a more durable and effective strategy. This broader approach prevents a narrow focus on glucose while missing the deeper physiology underneath.
Takeaway
Severe insulin resistance syndromes require thoughtful interpretation because similar symptoms can come from very different causes. Acanthosis, androgen excess, high triglycerides, fatty liver, unusual fat distribution, and extreme insulin needs all deserve careful attention.
Recognizing patterns over isolated numbers allows a more precise and meaningful clinical approach, as mentioned earlier.
At our practice in Montgomery County, Maryland, and through virtual care, we evaluate severe insulin resistance through personalized, comprehensive care. We connect glucose patterns, hormones, lipids, blood pressure, body composition, and long-term metabolic risk to build a meaningful strategy from multiple angles.
- Severe Insulin Resistance Syndromes. The Journal of Clinical Investigation. 2021. Angelidi AM, Filippaios A, Mantzoros CS.
- Free Fatty Acid Processing Diverges in Human Pathologic Insulin Resistance Conditions. The Journal of Clinical Investigation. 2020. Sekizkardes H, Chung ST, Chacko S, et al.
- Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study. Diabetes Care. 2018. Klubo-Gwiezdzinska J, Lange M, Cochran E, et al.
- Case 10-2024: A 46-Year-Old Woman with Hyperglycemia Refractory to Insulin Therapy. The New England Journal of Medicine. 2024. Fourman LT, Tsai LL, Brown RJ, O’Rahilly S.
- Genetic Syndromes of Severe Insulin Resistance. Current Opinion in Genetics & Development. 2018. Melvin A, O’Rahilly S, Savage DB.
- Acquired and Inherited Lipodystrophies. The New England Journal of Medicine. 2004. Garg A.
- Metreleptin-Mediated Improvements in Insulin Sensitivity Are Independent of Food Intake in Humans With Lipodystrophy. The Journal of Clinical Investigation. 2018. Brown RJ, Valencia A, Startzell M, et al.
- Perilipin Deficiency and Autosomal Dominant Partial Lipodystrophy. The New England Journal of Medicine. 2011. Gandotra S, Le Dour C, Bottomley W, et al.
- Insulin Receptor Family Autoantibodies in Patients With Type B Insulin Resistance. The Journal of Clinical Endocrinology and Metabolism. 2026. Lee JE, Chillon TS, Minich WB, et al.
- Therapeutic Indications and Metabolic Effects of Metreleptin in Patients With Lipodystrophy Syndromes: Real-Life Experience From a National Reference Network. Diabetes, Obesity & Metabolism. 2022. Mosbah H, Vantyghem MC, Nobécourt E, et al.
- Systematic Review-Type B Insulin Resistance With Isolated Hypoglycemia and Suppressed Insulin. The Journal of Clinical Endocrinology and Metabolism. 2024. Brown N, Elston MS.
- Serum Proteomics of Insulin Resistance Disorders Distinguish MASLD From Lipodystrophy and Insulin Receptor Defects. The Journal of Clinical Endocrinology and Metabolism. 2026. Mironova M, Wing A, Abel BS, et al.
About Dr. Gerti Tashko, MD
Dr. Gerti Tashko, MD, is an endocrinologist in Montgomery County, Maryland. He is uniquely quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. His practice delivers root-cause-focused metabolic and endocrine care, available virtually and in person. He uses advanced diagnostics, personalized nutrition, and preventive medicine to improve long-term health.




